-

AgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global Competition

Selected among Top 40 teams worldwide for Milestone 1 Award in 7-year challenge to restore age-related decline and extend healthy human lifespan.

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, has been selected as a Semi-Finalist in the landmark XPRIZE Healthspan competition. The first-of-its-kind longevity telehealth platform joins a select group of 40 global teams receiving Milestone 1 awarding of the $101 million, seven-year competition to extend healthy human healthspan by at least 10 years in adults aged 50–80, with a goal of 20 years, in one year or less. XPRIZE Healthspan is designed to spark bold scientific breakthroughs in healthy aging with the potential to benefit humanity at scale.

“Our work is grounded in the idea that aging is not a single condition, but a complex, multi-system process that requires integrated, personalized care strategies,” said Stefanie Morgan, Ph.D, Vice President of Research and Applied Sciences. “Our goal is to bring rigorous, science-backed longevity care out of the lab and into people’s lives in a way that’s accessible, safe, and clinically meaningful.”

The global longevity economy is projected to exceed $610 billion by 2025, driving an increased demand for solutions that allow people to live healthier, longer. Age-related diseases account for over 55% of global healthcare spending, showing the need for scalable, evidence-based interventions that target the root causes of aging. AgelessRx’s nomination underscores the potential to bring high-impact, clinically guided longevity care at scale while capturing a rapidly growing global market.

Launched nearly three decades ago, XPRIZE was created to incentivize breakthrough solutions in the most critical arenas of science and technology, from spaceflight and climate change to health and human potential. The Healthspan competition, announced in late 2023, is its most ambitious aging-focused initiative yet.

“At AgelessRx, our mission has always been to give people control over their healthspan through evidence-based, clinically guided solutions,” said Dr. Sajad Zalzala, Chief Medical Officer and Co-Founder of AgelessRx. “The PEARL trial allowed us to pioneer the infrastructure and protocols for real-world, decentralized longevity care — laying the foundation for our XPRIZE Healthspan approach. We're excited to continue advancing care that restores years and vitality, not just adds time.”

As part of this phase of the competition, AgelessRx has launched a pilot clinical study enrolling participants aged 65–80 to evaluate the functional and biological impact of its multifaceted healthspan-extending strategy. Participants will undergo:

  • DEXA scans for muscle and fat distribution
  • Cognitive testing and immune biomarker panels
  • Wearable health tracking, all delivered under the guidance of licensed longevity specialists

This 6-month study will help validate the safety and provide indications of longer-term efficacy of AgelessRx’s unique approach to healthspan extension, and will lay the foundation for future large-scale trials and broader clinical adoption.

By combining clinical precision, digital access, and a mission to democratize science-backed longevity care, AgelessRx is proud to stand at the forefront of the healthspan revolution. As demand grows for proven, preventive solutions, this XPRIZE milestone reinforces AgelessRx’s role in delivering therapies that allow users to proactively take control of their health journeys.

To learn more about AgelessRx’s approach to extending healthspan, or to apply for the upcoming pilot study, visit agelessrx.com.

About AgelessRx

AgelessRx is at the forefront of the longevity revolution, offering clinically validated, cutting-edge solutions and preventive treatments aimed at extending life expectancy and enhancing quality of life. AgelessRx also continues to advance the field of longevity science by conducting ongoing research and clinical trials. Through its online platform, AgelessRx provides easy access to innovative healthcare services, with an emphasis on customer satisfaction, affordability, and the pursuit of a future where extended healthspan is a reality for everyone. Follow AgelessRx on Instagram, X, Facebook, and LinkedIn.

Contacts

Media contact:
JackTaylor PR
agelessrx@jacktaylorpr.com

AgelessRx


Release Versions

Contacts

Media contact:
JackTaylor PR
agelessrx@jacktaylorpr.com

More News From AgelessRx

AgelessRx Launches Methylene Blue, Pioneering Accessible Cognitive Longevity Solutions

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, announces the launch of its newest offering: Methylene Blue capsules. Recent studies suggest that Methylene Blue may support focus, brain health, and cellular energy production, all in a mess-free, convenient capsule format. The launch of Methylene Blue marks AgelessRx’s launch into the cognitive health market valued at $11.55 billion in 2025 and projected to reach $40.27 billion by 2035. The global M...

AgelessRx Expands Offerings to Include Oral GLP-1 Drops to Advance Metabolic Health and Longevity Science

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable alternatives to medications that may support metabolic health management1 and counter the effects of aging2, AgelessRx continues to empower individuals to live longer, healthier lives. Optimal metabolic health is a foundational component of longevity. Dysregulated glu...

AgelessRx Enters Sleep Health Category, Underscoring Critical Role Sleep Plays in Healthspan and Lifespan

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, today announced its entry into the sleep health category, building on its commitment to redefine aging and improve quality of life. With a strong emphasis on research-backed solutions, AgelessRx’s sleep program provides personalized sleep treatment plans, and two new products–prescription Trazodone and natural, over-the-counter (OTC) Tran-Q Sleep Supplement–alongside easy-to-adopt lifestyle recommenda...
Back to Newsroom